​

Regencell Bioscience Ownership | Who Owns Regencell Bioscience?

OverviewChart

Regencell Bioscience Ownership Summary

Regencell Bioscience is owned by 0.24% institutional investors, 88.82% insiders, and 10.94% retail investors. Ubs group is the largest institutional shareholder, holding 0.22% of RGC shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.05% of its assets in Regencell Bioscience shares.

RGC Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockRegencell Bioscience0.24%88.82%10.94%
SectorHealthcare Stocks 57.43%9.41%33.16%
IndustrySpecialty & Generic Drug Manufacturers Stocks25.54%11.10%63.36%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ubs group29.22K0.22%$144.34K
Blackrock238.000.00%$800.00
Blackrock funding, inc. /de238.000.00%$1.18K
Qube research---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Blackrock238.00-$800.00
Ubs group29.22K-$144.34K
Qube research---
Blackrock funding, inc. /de238.00-$1.18K

Top Buyers

HolderShares% AssetsChange
Ubs group29.22K-11.34K
Blackrock238.00--
Blackrock funding, inc. /de238.00--
Qube research---13.00

Top Sellers

HolderShares% AssetsChange
Qube research---13.00
Blackrock238.00--
Blackrock funding, inc. /de238.00--
Ubs group29.22K-11.34K

Sold Out

HolderChange
Qube research-13.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024350.00%31,55674.21%-1251.51%2---
Sep 30, 20242-33.33%18,1143117.41%-748234.88%2---100.00%
Jun 30, 20243-563-65.90%-2685.04%--1-
Mar 31, 20243-1,651-89.87%-80.85%--100.00%1-
Dec 31, 20233-25.00%16,3042362.84%-460128.85%1-66.67%--

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Nasdaq Composite Index6.82K0.05%-

Recent Insider Transactions

DateNameRoleActivityValue
Aug 29, 2017BELL THOMAS D JR-Buy$369.00K
Aug 25, 2017KAPLAN STEPHEN A-Buy$148.70K
Aug 24, 2017Ownby David EVP, CFO and TreasurerBuy$105.30K
Mar 09, 2017BRANDOW PETER B EVP, General Counsel, Sec.Sell$455.24K
Mar 09, 2017DUNN GREGORY W President and COOSell$577.01K

RGC Ownership FAQ

Who Owns Regencell Bioscience?

Regencell Bioscience shareholders are primarily institutional investors at 0.24%, followed by 88.82% insiders and 10.94% retail investors. The average institutional ownership in Regencell Bioscience's industry, Specialty & Generic Drug Manufacturers Stocks, is 25.54%, which Regencell Bioscience falls below.

Who owns the most shares of Regencell Bioscience?

Regencell Bioscience’s largest shareholders are Ubs group (29.22K shares, 0.22%), Blackrock (238 shares, 0.00%), and Blackrock funding, inc. /de (238 shares, 0.00%). Together, they hold 0.23% of Regencell Bioscience’s total shares outstanding.

Does Blackrock own Regencell Bioscience?

Yes, BlackRock owns 0.00% of Regencell Bioscience, totaling 238 shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 800$. In the last quarter, BlackRock decreased its holdings by 0 shares, a 0% change.

Who is Regencell Bioscience’s biggest shareholder by percentage of total assets invested?

Blackrock is Regencell Bioscience’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 238 Regencell Bioscience shares, valued at 800$.

Who is the top mutual fund holder of Regencell Bioscience shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of Regencell Bioscience shares, with 0.05% of its total shares outstanding invested in 6.82K Regencell Bioscience shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools